Cases of syphilis and gonorrhoea have tripled and quadrupled, respectively, since 2015, highlighting the need for effective treatments.

Concept Life Sciences has signed a strategic partnership with OpenBench to deliver success-based drug discovery services targeted at early-stage biotech companies.

The tender offer is for €51.29 per share, representing a 13% premium on Recordati’s share price before the takeover was first disclosed.

Gilead Sciences has concluded its acquisition of Germany-based biotechnology company Tubulis in a transaction valued at up to $5bn.

Gilead will donate vials of its antifungal medication AmBisome to help global efforts in eliminating visceral leishmaniasis.

Bristol Myers Squibb (BMS) has signed a strategic agreement with Anthropic to implement its Claude platform across its global operations.

QIAGEN’s Digital Insights bioinformatics division is set to integrate NVIDIA’s accelerated computing and the BioNeMo platform to enhance AI-driven drug discovery.

The healthcare team covers Q1 results from pharma and medtech companies and provides a wrap-up of the key takeaways ...

Eli Lilly has acquired Engage Bio and its preclinical, non-viral DNA delivery platform. Credit: Tada Images / Shutterstock.com. Pharmaceutical giant Eli Lilly has agreed to acquire Engage Biologics ...

As regulatory expectations rise and advanced therapies push cold-chain complexity, 3PLs are investing in validated infrastructure, network-wide quality systems, and data-driven visibility.

FUJIFILM Cellular Dynamics has opened a new headquarters and iPSC manufacturing facility in Madison, Wisconsin, US.

SERB Pharmaceuticals has signed an agreement to acquire exclusive development and commercialisation rights to Idefirix from Hansa Biopharma for a total of $133.6m.